Secondary prevention of hepatitis C virus-related hepatocellular carcinoma

被引：3
作者：
Lin, SM
Chu, CM
机构：
[1] Chang Gung Mem Hosp, Liver Res Unit, Taipei 105, Taiwan
[2] Chang Gung Univ, Taipei, Taiwan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2005年 / 20卷 / 10期
关键词：
D O I：
10.1111/j.1440-1746.2005.04016.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1475 / 1477
页数：3
相关论文
共 19 条
[1]   INTRAHEPATIC RECURRENCE AFTER RESECTION OF HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS [J].
BELGHITI, J ;
PANIS, Y ;
FARGES, O ;
BENHAMOU, JP ;
FEKETE, F .
ANNALS OF SURGERY, 1991, 214 (02) :114-117
[2]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[3]   Prevention of hepatitis C virus-related hepatocellular carcinoma [J].
Heathcote, EJ .
GASTROENTEROLOGY, 2004, 127 (05) :S294-S302
[4]   Differences in treatment outcome for hepatitis C among ethnic groups [J].
Hepburn, MJ ;
Hepburn, LM ;
Cantu, NS ;
Lapeer, MG ;
Lawitz, EJ .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (03) :163-168
[5]   Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus [J].
Hung, CH ;
Lee, CM ;
Wang, JH ;
Tung, HD ;
Chen, CH ;
Lu, SN .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (10) :1553-1559
[6]   Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer [J].
Ikeda, K ;
Arase, Y ;
Saitoh, S ;
Kobayashi, M ;
Suzuki, Y ;
Suzuki, F ;
Tsubota, A ;
Chayama, K ;
Murashima, N ;
Kumada, H .
HEPATOLOGY, 2000, 32 (02) :228-232
[7]   Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy - Result of multivariate analysis [J].
Ko, S ;
Nakajima, Y ;
Kanehiro, H ;
Hisanaga, M ;
Aomatsu, Y ;
Kin, T ;
Yagura, K ;
Ohyama, T ;
Nishio, K ;
Ohashi, K ;
Sho, M ;
Yamada, T ;
Nakano, H .
ANNALS OF SURGERY, 1996, 224 (05) :591-595
[8]   Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma [J].
Kubo, S ;
Nishiguchi, S ;
Shuto, T ;
Tanaka, H ;
Tsukamoto, T ;
Hirohashi, K ;
Ikebe, T ;
Wakasa, K ;
Kuroki, T ;
Kinoshita, H .
JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (02) :162-170
[9]   Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy [J].
Kubo, S ;
Nishiguchi, S ;
Hirohashi, K ;
Tanaka, H ;
Shuto, T ;
Kinoshita, H .
BRITISH JOURNAL OF SURGERY, 2002, 89 (04) :418-422
[10]   Effects of long-term postoperative interferon-α therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma -: A randomized, controlled trial [J].
Kubo, S ;
Nishiguchi, S ;
Hirohashi, K ;
Tanaka, H ;
Shuto, T ;
Yamazaki, O ;
Shiomi, S ;
Tamori, A ;
Oka, H ;
Igawa, S ;
Kuroki, T ;
Kinoshita, H .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (10) :963-967
12